Dr. Kexin Huang
VERIFIED TECHNICAL DOSSIERSources checked

Dr. Kexin Huang

AI Bio-Medicine Researcher

2 Verified ArtifactsSource Checked & Attributed

Verified Proof of Work Artifacts

2 items cataloged

Each artifact below represents an authenticated research publication, production code repository, or technical architectural framework directly authored or co-created by Dr. Kexin Huang. Every entry undergoes editorial source verification.

#1
RESEARCH Checked Sep 22, 2026

A Foundation Model for Clinician-Centered Drug Repurposing with TxGNN

First author of the Nature Medicine 2024 paper introducing TxGNN, a geometric foundation model trained on a medical knowledge graph of 17,080 diseases to identify drug repurposing opportunities for rare diseases with clinician-interpretable rationales.

Model & Execution Context:Graph Neural Networks, 17k disease knowledge graph, clinician explanatory subgraphs.
Scope & Limitations

Predictions require in vitro wet-lab assay validation and clinical trials before therapeutic efficacy can be established.

#2
IMPLEMENTATION Checked Sep 22, 2026

Therapeutics Data Commons: Machine Learning Benchmarks for Drug Discovery

Co-founded and engineered Therapeutics Data Commons (TDC), the de-facto open-source Python library standardizing 66 therapeutic machine learning tasks across small molecules, antibodies, target proteins, and clinical outcomes.

Model & Execution Context:PyTorch Geometric, RDKit integration, 66 benchmark tasks across 22 problem formulations.
Scope & Limitations

Public biological datasets often carry historical batch effects that require careful domain covariate shift evaluation.